Abiopharma

Clinical trial NCT07300085 updates: 1. completion date: 2026-12-01 → 2026-12-31 2. primary completion date: 2026-12-01 → 2026-12-31 3. enrollment: 100 → 710 participants

Clinical trial NCT06953271 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2025-05-15 → 2025-08-01 3. completion date: 2027-01-01 → 2027-04-01 4. primary completion date: 2026-05-01 → 2027-01-30

Clinical trial NCT07552272 updates: 1. start date: 2026-07-01 → 2026-09-01 2. completion date: 2031-07-01 → 2031-09-01 3. primary completion date: 2031-07-01 → 2031-09-01

Clinical trial NCT05889728 updates: 1. status: UNKNOWN → COMPLETED 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06916078 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-07-13 3. primary completion date: 2026-07-01 → 2026-07-13 4. enrollment: 33 → 30 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05261204: status: ENROLLING_BY_INVITATION → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07232030: status: ENROLLING_BY_INVITATION → RECRUITING.

Clinical trial NCT07023731 updates: 1. completion date: 2029-04-02 → 2026-11-30 2. primary completion date: 2027-11-30 → 2026-11-30

Clinical trial NCT06444347: primary completion date: 2026-07-01 → 2027-07-01.

Clinical trial NCT07128303: enrollment: 178 → 476 participants.

Clinical trial NCT04430075 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2025-12-31 → 2025-09-04

Clinical trial NCT05356741 updates: 1. completion date: 2027-08-16 → 2028-04-01 2. primary completion date: 2027-08-16 → 2028-04-01

Clinical trial NCT00117936 updates: 1. status: UNKNOWN → NOT_YET_RECRUITING 2. start date: 2020-03-01 → 2027-09-01 3. completion date: 2023-03-01 → 2030-06-15 4. primary completion date: 2022-03-01 → 2029-11-15

Clinical trial NCT06101134: completion date: 2027-08-31 → 2027-02-26.

Clinical trial NCT04824989 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2025-04-30 → 2027-02-01 3. primary completion date: 2025-04-30 → 2027-02-01 4. enrollment: 500 → 305 participants 5. enrollment type: ESTIMATED → ACTUAL 6. collaborators added: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)